CRP Publications
Type
Journal
Year
2019
Description
M.A. A´vila-Rodri´guez, E. Aguilar-Orti´z, A.R. Jalilian , J.C. Manrique-Aias, A. Zarate-Morales, A. Flores-Moreno, A simple and efficient method to recover Nickel-64 from electrolytic solutions, Appl. Radiat. Isot. 145, 55-58 (2019).
Country/Organization
Mexico
Type
Journal
Year
2020
Description
J. Carrasco-Herna´ndez, J. Ramos-Me´ndez, B. Faddegon, A.R. Jalilian, M. Moranchel, M.A. A´vila-Rodri´guez. Monte Carlo track-structure for the radionuclide Copper-64: Characterization of S-values, nanodosimetry and quantification of direct damage to DNA, Phys. Med. Biol. (2020).
Country/Organization
Mexico
Type
Conference
Year
2016
Description
S. Ait-Mohand, V. Dumulon-Perreault, F. Benard B. Guérin. Design optimization of a new 64Cu/NOTA truncated NPY analog with improved stability and Y1 affinity, the first step toward successful breast cancer PET Imaging. J Nucl Med, 2016, 57:1076.
Country/Organization
Canada
Type
conference
Year
2018
Description
B. Guérin, Outils pour l’imagerie TEP, une ouverture vers le développement de théranostiques. Lecture at UQAM's chemistry department, Montreal, Quebec, CA, November 15, 2018.
Country/Organization
Canada
Type
Thesis
Year
2019
Description
N. Mansour, PhD student
Country/Organization
CANADA
Type
Conference
Year
2019
Description
Halldorsdottir, H. Flexible Copper-64-nanoparticle-based cell labeling system allows for in vivo tracking of adoptively transferred T-cells by PET/CT. JOURNAL FOR IMMUNOTHERAPY OF CANCER 2019, 7.
Country/Organization
Denmark
Type
Conference
Year
2019
Description
Pedersen, K.S.; Zhuravlev, F. Towards continuous cyclotron production of PET radiometals: Membrane-based liquid-liquid extraction in flow of gallium-68, copper-64, zirconium-89, and titanium-45. Journal of Labelled Compounds and Radiopharmaceuticals 2019, 62.
Country/Organization
Denmark
Type
Conference
Year
2019
Description
Kristensen, L.K. PET imaging of tumor-immune status for response prediction and treatment monitoring in syngeneic mouse models. Cancer Research 2019, 79, 1130.
Country/Organization
Denmark
Type
Post doctoral Research Protocol:
Year
2017-NOW
Description
Edgar A. Aguilar-Ortiz, Synthesis, characterization and evaluation of macrocyclic porphyrin systems, as potential chelate agents for 64Cu-radiopharmaceuticals.
Country/Organization
MEXICO
Type
Peer-reviewed Journal Article
Year
2017
Description
Avila-Rodriguez, M.A., Rios, C., Carrasco-Hernandez, J., Manrique-Arias, J.C., Martinez-Hernandez, F.O. Garci´a-Pe´rez, A.R. Jalilian, E. Martinez-Rodriguez, M.E. Romero-Pin~a, A. Diaz-Ruiz, Biodistribution and Radiation Dosimetry of [64Cu]Copper Dichloride: First-in-Human Study in Healthy Volunteers, Eur J Nucl Med Mol Imaging Research. 7, 98
Country/Organization
MEXICO
Type
Ph.D Dissertation/Master’s Theses
Year
2017
Description
Jhonatan Carrasco-Hernandez (Doctorate’s degree), Evaluating the potential of [64Cu]CuCl2 as a theranostic agent.
Country/Organization
MEXICO
Type
Peer-reviewed Journal Article
Year
2016
Description
J.C. Manrique-Arias, J. Carrasco-Herna´ndez, P.G. Reyes, M.A. Avila-Rodriguez, Biodistribution in rats and human dosimetry estimation of 64CuCl2, a potential theranostic tracer, Appl. Radiat. Isot. 115, 18-22
Country/Organization
MEXICO
Type
Journal
Year
2019
Description
E. Aguilar-Orti´z, A.R. Jalilian, M.A. Avila-Rodriguez, Synthesis, characterization and evaluation of a 64Cu-labeled macrocyclic-porphyrin as a potential chelator for Cu-based radiopharmaceuticals, J. Radioanal. Nucl. Chem. 320, 79-86 (2019).
Country/Organization
Mexico
Type
Conference
Year
2019
Description
J. Carrasco-Hernandez, J. Ramos-Mendez, M.A. Avila-Rodri´guez, Determination of S-values and characterization of direct damage to DNA induced by Auger electrons from Copper-64, EJNMMI 46, S197 (2019).
Country/Organization
Mexico
Type
Conference
Year
2019
Description
Kjaer, A. Cu-64-DOTATATE somatostatin receptor Imaging in neuroendocrine tumors: experience from 500 patients at Copenhagen ENETS Center of Excellence. Journal of Nuclear Medicine 2019, 60, 504.
Country/Organization
Denmark
Type
Journal
Year
2018
Description
E. Aguilar-Orti´z, A.R. Jalilian, M.A. Avila-Rodriguez, Porphyrins as Ligands for 64Copper: Background and Trends, Med. Chem. Comm. 9, 1577-88 (2018).
Country/Organization
Mexico
Type
conference
Year
2019
Description
Preparation and biological assessment of 64Cu-NOTA-anti ROR1 as a Radioimmunoconjugate for Diagnosis of ROR1+ breast cancer by PET, 2nd International Symposium of Trends of Radiopharmaceuticals (IAEA), Location: Vienn, Austria, 2019
Country/Organization
Iran
Type
Ph.D Dissertation/Master’s Theses
Year
2017
Description
Carlos A. Gomez-Peralta (Master’s degree), Quantitative analysis of the brain biodistribution of [64Cu]CuCl2 in patients with Parkinson’s disease.
Country/Organization
MEXICO
Type
Journal
Year
2017
Description
M.A. Avila-Rodriguez, C. Rios, J. Carrasco-Hernandez, J.C. Manrique-Arias, R. Martinez-Hernandez, F.O. Garci´a-Pe´rez, A.R. Jalilian, E. Martinez-Rodriguez, M.E. Romero-Pin~a, A. Diaz-Ruiz, Biodistribution and Radiation Dosimetry of [64Cu]Copper Dichloride: First-in-Human Study in Healthy Volunteers, EJNMMI Res. 7, 98 (2017).
Country/Organization
Mexico
Type
review
Year
2020
Description
IAEA contribution to the development of copper-64 radiopharmaceuticals for theranostic applications, Department of Nuclear Sciences and Applications, International Atomic Energy Agency (IAEA), Vienna International Centre, PO Box 100, 1400, Vienna, Austria, 20 Contributers
Country/Organization
IAEA
Type
conference
Year
2019
Description
Authors: Irfan Ullah Khan, Rizwana Zahoor, Abubaker Shahid, Fozia Iram, Capacity Building in Theranostics: Initial Experience at INMOL-Lahore being First Theranostics Centre in Pakistan, Theranostics World Congress 2019; held in Jeju, Korea
Country/Organization
Pakistan
Type
Journal
Year
2019
Description
Rodney John Hicks, Price Jackson, Grace Kong, et al. First-in-human trial of 64Cu-SARTATE PET imaging of patients with neuroendocrine tumours demonstrates high tumor uptake and retention, potentially allowing prospective dosimetry for peptide receptor radionuclide therapy. J Nucl Med. 2019 Jun;60(6):777-785
Country/Organization
Australia
Type
Thesis
Year
2019
Description
M. Paquette, PhD, Post-Doc
Country/Organization
CANADA
Type
Conference
Year
2017
Description
C. Zhang, J. Pan, K.-S. Lin, J. Zeisler, B. Guerin, and F. Benard. Stabilizing truncated peptides targeting the neuropeptide Y1 receptor for cancer imaging. J Nucl Med 2017 58:693. Society of Nuclear Medicine Annual Meeting, SNMMI 2017, Denver, Colorado, USA, June 10-14, 2017. JNM 2017
Country/Organization
Canada
Type
Peer-reviewed Journal Article
Year
2017
Description
Davies, G.; Rolle, A.-M.; Maurer, A.; Spycher, P. R.; Schillinger, C.; Solouk-Saran, D.; Hasenberg, M.; Weski, J.; Fonslet, J.; Dubois, A.; et al. Towards Translational ImmunoPET/MR Imaging of Invasive Pulmonary Aspergillosis: The Humanised Monoclonal Antibody JF5 Detects Aspergillus Lung Infections In-vivo. Theranostics 2017, 7 (14), 3398–3414.
Country/Organization
DENMARK
Type
Conference
Year
2019
Description
E. Aguilar-Ortiz, A. Jalilian, M. Ávila-Rodríguez, Synthesis, characterization and labeling of [64Cu]-5-(4aminophenyl)-10,15,20-triphenyl porphyrine as a potential PET imaging chelate, Nucl. Med. Biol. 72–73 (2019) 36.
Country/Organization
Mexico
Type
Journal
Year
2019
Description
Kristensen, L.K. PET imaging of tumor-immune status for response prediction and treatment monitoring in syngeneic mouse models. Cancer Research 2019, 79, 1130
Country/Organization
Denmark
Type
Thesis
Year
2019
Description
Jhonatan Carrasco-Hernandez (Doctorate), Evaluating the potential of [64Cu]CuCl2 as a theranostic agent.
Country/Organization
MEXICO
Type
Thesis
Year
2019
Description
Edgar A. Aguilar-Ortiz (PostDoc), Synthesis, characterization and evaluation of macrocyclic porphyrine systems, as potential chelate agents for 64Cu-radiopharmaceuticals.
Country/Organization
MEXICO
Type
Journal
Year
2018
Description
N. Mansour, M. Paquette, S. Ait-Mohand, V. Dumulon-Perreault, B. Guérin. Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [64Cu]-DOTHA2-PEG-RM26. Nucl. Med. Biol. 2018, 56, 31–38.
Country/Organization
Canada
Type
Abstracts from the Proceedings of a Meeting
Year
2017,
Description
M.A. Avila-Rodriguez, C. Rios, J. Carrasco-Hernandez, J.C. Manrique-Arias, R. Martinez-Hernandez, F.O. Garci´a-Pe´rez, E. Martinez-Rodriguez, M.E. Romero- Pin~a, A.R. Jalilian , A. Diaz-Ruiz, PET-based biodistribution and radiation dosimetry of [64Cu]copper dichloride, first-in- human healthy volunteer evaluation (Oral presentation), EANM 2017 Congress, Vienna, Austria. (Abstract published in EJNMMI 44:S359).
Country/Organization
MEXICO
Type
Thesis
Year
2018
Description
Mário Gutfilen Grünbaum - Development of new radiopharmaceuticals with Cu-64: translational studies. Undergraduate student.
Country/Organization
BRAZIL
Type
Ph.D Dissertation/Master’s Theses
Year
2016
Description
Ms.c Thesis: Preparation and Quality Control of 64Cu-PCTA- Anti MUC1 as radioimmunoconjugate for PET Imaging. Fatemeh Karami . Started from 2016. Ongoing
Country/Organization
IRAN
Type
Thesis
Year
2018
Description
M. van Bezoen,, internship in the Baccalaureate degree entitled:”Synthesis and validation of cold refrence compounds Cu-, Ga- and AlF-ACUPA-benzyl-TU-NOTA
Country/Organization
NETHERLANDS
Type
Ph.D Dissertation/Master’s Theses
Year
2018
Description
Romano Silviano Bonito Hendriko Schreuder, Development of 64Cu-labeled radiopharmaceuticals for neuroendocrine tumor detection with positron emission tomography: A comparison between 64Cu-NODAGA-NOC, 68Ga-NODAGA-NOC and 68Ga-DOTA-TOC
Country/Organization
THE NETHERLANDS
Type
Journal
Year
2017
Description
Christensen, A.; Juhl, K.; Persson, M.; Charabi, B.W.; Mortensen, J.; Kiss, K.; Lelkaitis, G.; Rubek, N.; von Buchwald, C.; Kjær, A. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: Proof-of-concept in orthotopic xenograft model. Oncotarget 2017, 8, 15407–15419
Country/Organization
Denmark
Type
Journal
Year
2017
Description
Jensen, A.T.I. PET imaging with copper-64 as a tool for real-time in vivo investigations of the necessity for crosslinking of polymeric micelles in nanomedicine. Journal of Labelled Compounds and Radiopharmaceuticals 2017, 60, 366–374
Country/Organization
Denmark
Type
conference
Year
2019
Description
B. Guérin, Optimizing care for prostate cancer patients using molecular imaging and targeted radioligand therapy. 11th Scientific Day QBIN, Montreal, Quebec, CA, March 29th, 2019.
Country/Organization
Canada
Type
conference
Year
2019
Description
Preparation and Preclinical Evaluation of 64Cu-NOTA-anti MUC1 as a Radioimmunoconjugate for Diagnosis of MUC1+ breast cancer by PET, 2nd International Symposium of Trends of Radiopharmaceuticals (IAEA), Location: Viena, Austria, 2019
Country/Organization
Iran
Type
Journal
Year
2018
Description
eppesen, T.E. Site-Specific Cu-64 Labeling of the Serine Protease, Active Site Inhibited Factor Seven Azide (FVIIai-N-3), Using Copper Free Click Chemistry. BIOCONJUGATE CHEMISTRY 2018, 29, 117–125
Country/Organization
Denmark
Type
Journal
Year
2018
Description
hristensen, E.; Henriksen, J.R.; Jørgensen, J.T.; Amitay, Y.; Schmeeda, H.; Gabizon, A.A.; Kjær, A.; Andresen, T.L.; Hansen, A.E. Folate receptor targeting of radiolabeled liposomes reduces intratumoral liposome accumulation in human KB carcinoma xenografts. International Journal of Nanomedicine 2018, 13, 7647–7656.
Country/Organization
Denmark
Type
Abstracts from the Proceedings of a Meeting
Year
2017
Description
"Preparation and preclinical evaluation of 64Cu-NOTA-anti MUC1 as a radioimmunoconjugate for diagnosis of MUC1 breast cancer by PET" (EANM 17)- 2017-Vienna-Austria
Country/Organization
IRAN
Type
Conference
Year
2016
Description
N. Mansour, M. Paquette, S. Ait-Mohand, V. Dumulon-Perreault, R. Lecomte, B. Guérin. A Novel Radiolabeled Peptide for PET Imaging of Prostate Cancer: 64Cu-DOTHA2-PEG-RM26: ESRR’16 – 18th European Symposium on Radiopharmacy and Radiopharmaceuticals, April 07-10, 2016, Salzburg, Austria. EJNMMI Radiopharm. Chem. 2016, S1 OP27.
Country/Organization
Canada
Type
Journal
Year
2016
Description
J.C. Manrique-Arias, J. Carrasco-Herna´ndez, P.G. Reyes, M.A. Avila-Rodriguez, Biodistribution in rats and human dosimetry estimation of 64CuCl2, a potential theranostic tracer, Appl. Radiat. Isot. 115, 18-22 (2016).
Country/Organization
Mexico
Type
Journal
Year
2019
Description
Anjum, Rukhsana; Palanimuthu, Duraippandi; Kalinowski, Danuta; Lewis, William; Park, Kyung Chan; Kovacevic, Zaklina; Khan, Irfan Ullah; Richardson, Des; Synthesis, Characterization and In Vitro Anti-Cancer Activity of Copper and Zinc Bis (Thiosemicarbazone) Complexes; Inorg. Chem. 2019, 58 (20): 13709-13723. DOI: 10.1021/acs.inorgchem.9b01281
Country/Organization
Pakistan
Type
Conference
Year
2017
Description
M. Paquette, V. Dumulon-Perreault, S. Ait-Mohand, B. Guérin. A New 64Cu-Labeled, Metabolic-Resistant Peptide with Nanomolar Affinity for NPY-Y1R for Breast Cancer Targeting. EANM’17, Vienna, Austria, October 21-25, 2017. EJNMMI 2017
Country/Organization
Canada
Type
conference
Year
2019
Description
Preparation and biological assessment of 64Cu-NOTA-anti EGFR as a Radioimmunoconjugate for Diagnosis of EGFR+ ESCC by PET
Country/Organization
Iran
Type
Abstracts from the Proceedings of a Meeting
Year
2016
Description
Z. Szucs 1*, B. Alirezapour. Simultaneous production of 55Co, 57Ni and 64Cu for PET imaging; 5th Workshop of the Decay Data Evaluation Project
Country/Organization
IRAN
Type
Journal
Year
2018
Description
Hansen, A.E.; Fliedner, F.P.; Henriksen, J.R.; Jørgensen, J.T.; Clemmensen, A.E.; Børresen, B.; Elema, D.R.; Kjær, A.; Andresen, T.L. Liposome accumulation in irradiated tumors display important tumor and dose dependent differences. Nanomedicine: Nanotechnology, Biology and Medicine 2018, 14, 27–34.
Country/Organization
Denmark
Type
conference
Year
2018
Description
B. Guérin, Tools for peptide radiolabeling, Clara Benson Award Lecture, Sponsored by the Canadian Council of University Chemistry Chairs (CCUCC).101st Canadian Chemistry Conference and Exhibition, May 27-31, 2018; Edmonton, AB, Canada.
Country/Organization
Canada
Type
Journal
Year
2018
Description
Børresen, B.; Henriksen, J.R.; Clergeaud, G.; Jørgensen, J.S.; Melander, F.; Elema, D.R.; Szebeni, J.; Engelholm, S.A.; Kristensen, A.T.; Kjær, A.; et al. Theranostic Imaging May Vaccinate against the Therapeutic Benefit of Long Circulating PEGylated Liposomes and Change Cargo Pharmacokinetics. ACS Nano 2018, 12, 11386–11398
Country/Organization
Denmark
Type
Journal
Year
2020
Description
Andersen, T.L.; Baun, C.; Olsen, B.B.; Dam, J.H.; Thisgaard, H. Improving Contrast and Detectability: Imaging with [55Co]Co-DOTATATE in Comparison with [64Cu]Cu-DOTATATE and [68Ga]Ga-DOTATATE. Journal of Nuclear Medicine, 2020, 61, 228–233
Country/Organization
Denmark
Type
Thesis
Year
2019
Description
V. Dumulon Perreault, M. Sc., Research assistant
Country/Organization
CANADA
Type
Thesis
Year
2019
Description
Benito Gongora Servin (Master), Preclinical evaluation and radiation dosimetry of 64Cu-DOTA-iPSMA.
Country/Organization
MEXICO
Type
Thesis
Year
2019
Description
Carlos A. Gomez-Peralta (Master), Quantitative analysis of the brain biodistribution of [64Cu]CuCl2 in patients with Parkinson’s disease.
Country/Organization
MEXICO
Type
conference
Year
2019
Description
Thaer Assaad, Abdul. Hamid Al Rayyes, and Mahmoud. Al-Ktaifani , In house preparation and biodistribution of 64Cu-ATSM, 64Cu-PTSM and 64Cu-DOTATATE for theranostic application. ISTR 2019, IAEA .
Country/Organization
Syria
Type
conference
Year
2015
Description
Dale Bailey et al. A Novel Theranostic Trial Design Using 64Cu/67Cu with Fully 3D Pre-Treatment Dosimetry. J Nucl Med, 2019, 60:S1 204.
Country/Organization
Australia
Type
conference
Year
2019
Description
Gutfilen B; Valentini G. Use of 64CuCl2 as a theranostic agent in gliblastoma tumor: A case report. 3rd International Cancer Conference & Expo, Baltimore, USA, 2019.
Country/Organization
Brazil
Type
Journal
Year
2016
Description
Behrouz Alirezapour, Mohammad Javad Rasaee, Amir Reza Jalilian, Saeed Rajabifar, Javad Mohammadnejad, Malihe Paknejad,Ehsan Maadi, Sedighe Moradkhani.” Development of 64Cu-DOTA-PR81 radioimmunoconjugate for MUC-1 positive PET imaging”. Nuclear Medicine and Biology. Vol. 43, No. 1, 2016
Country/Organization
Iran
Type
Thesis
Year
2019
Description
S. Ait-Mohand, PhD, Research professional
Country/Organization
CANADA
Type
Thesis
Year
2019
Description
Armando S. Ordoñez-Canul (Master), Copper-64 radiolabeled trastuzumab for PET molecular imaging of HER2+ tumors.
Country/Organization
MEXICO
Type
Conference
Year
2019
Description
M.A. Avila-Rodriguez, Preparation and quality control of ready for injection [64Cu]copper dichloride solution for theranostic applications, J. Label. Compd. Radiopharm. 62, S258 (2019).
Country/Organization
Mexico
Type
Journal
Year
2016
Description
Rubel Chakravarty, Sudipta Chakraborty, Raghumani Singh Ningthoujam, K. V. Vimalnath Nair, K. Shitaljit Sharma, Anand Ballal, Apurav Guleria, Amit Kunwar, Haladhar Dev Sarma, Rajesh Kumar Vatsa, Ashutosh Dash, Industrial-Scale Synthesis of Intrinsically Radiolabeled 64CuS Nanoparticles for Use in Positron Emission Tomography (PET) Imaging of Cancer. Ind. Eng. Chem. Res. 2016; 55, 48: 12407-12419.
Country/Organization
India
Type
Thesis
Year
2020
Description
Abdulrahman AlOmar (MSc), Synthesis and Preclinical Evaluation of 64Cu-NOTA-Folate: Potential PET radiopharmaceutical for Ovarian Cancer
Country/Organization
SAUDI ARABIA
Type
Journal
Year
2016
Description
Frellsen, A.F.; Hansen, A.E.; Jolck, R.I.; Kempen, P.J.; Severin, G.W.; Rasmussen, P.H.; Kjaer, A.; Jensen, A.T.I.; Andresen, T.L. Mouse Positron Emission Tomography Study of the Biodistribution of Gold Nanoparticles with Different Surface Coatings Using Embedded Copper-64. ACS Nano 2016, 10, 9887–9898.
Country/Organization
Denmark
Type
Journal
Year
2016
Description
Rubel Chakravarty, Sudipta Chakraborty, Ashutosh Dash 64Cu2+ Ions as PET Probe: An Emerging Paradigm in Molecular Imaging of Cancer. Mol Pharm. 2016; 13(11): 3601-3612.
Country/Organization
India
Type
Journal
Year
2019
Description
Hicks RJ, Jackson P, Kong G, Ware RE, Hofman MS, Pattison DA, Akhurst TA, Drummond E, Roselt P, Callahan J, Price R, Jeffery CM, Hong E, Noonan W, Herschtal A, Hicks LJ, Hedt A, Harris M, Paterson BM, Donnelly PS. 64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy. J Nucl Med. 2019 Jun;60(6):777-785.
Country/Organization
Australia
Type
conference
Year
2018
Description
Irfan Ullah Khan, Rizwana Zahoor, Nouroze Gul, Abubaker Shahid, Fozia Iram, Establishing Theranostics and Nano Theranostics in Pakistan
Country/Organization
Pakistan
Type
Journal
Year
2017
Description
Rubel Chakravarty, Sudipta Chakraborty, Apurav Guleria, Amit Kunwar, Haladhar Dev Sarma, Ashutosh Dash. Facile One-Pot Synthesis of Intrinsically Radiolabeled 64Cu-Human Serum Albumin Nanocomposite for Cancer Targeting. ChemistrySelect 2017; 2 (26): 8043-8051.
Country/Organization
India
Type
Conference
Year
2017
Description
M.A. Avila-Rodriguez, C. Rios, J. Carrasco-Hernandez, J.C. Manrique-Arias, R. Martinez-Hernandez, F.O. Garci´a-Pe´rez, E. Martinez-Rodriguez, M.E. Romero- Pin~a, A.R. Jalilian , A. Diaz-Ruiz, PET-based biodistribution and radiation dosimetry of [64Cu]copper dichloride, first-in-human healthy voluteer evaluation, EJNMMI 44, S359 (2017).
Country/Organization
Mexico
Type
Journal
Year
2016
Description
Petersen, A.L.; Henriksen, J.R.; Binderup, T.; Elema, D.R.; Rasmussen, P.H.; Hag, A.M.; Kjær, A.; Andresen, T.L. In vivo evaluation of PEGylated 64Cu-liposomes with theranostic and radiotherapeutic potential using micro PET/CT. European Journal of Nuclear Medicine and Molecular Imaging 2016, 43, 941–52.
Country/Organization
Denmark
Type
conference
Year
2019
Description
Gutfilen B; Valentini G. The role of 64CuCl2 as a theranostic agent in Alzhemeir’s Disease. International Conference on Alzheimer’s Disease & Dementia, Paris, França, 2019.
Country/Organization
Brazil
Type
conference
Year
2020
Description
2) Hailong Zhao, Tianwei Luo, Xuhu Huang, Zequan Li, Mengyi Chen, Ning Wang, Lin Xu, Hongyu Li. Preliminary biodistribution and PET imaging study of 64CuCl2 in model mice bearing melanoma. J. Isotopes.
Country/Organization
China
Type
Ph.D Dissertation/Master’s Theses
Year
2016
Description
Ms.c Thesis: Preparation and preclinical evaluation of 64Cu-NOTA- Anti MUC1 for PET Imaging of MUC1+ breast adeno Carcinoma. Started From 2017. Ongoing.
Country/Organization
IRAN
Type
conference
Year
2017
Description
M. Paquette, S. Ait-Mohand, V. Dumulon-Perreault, F. Bénard, B. Guérin. A Novel 64Cu/NOTA-labeled Peptide with High Metabolic-resistance and NPY-Y1R Affinity. 100th Canadian Chemistry Conference and Exhibition. Symposium in the Biological and Medicinal Chemistry Division, Metro Toronto Convention Centre. Canada May 30, 2017.
Country/Organization
Canada
Type
PATENT
Year
2019
Description
Fedor Zhuravlev; Krisitna Pedersen Separation of Radiometals, P20367WO, filed on August 5th, 2019
Country/Organization
DENMARK
Type
Ph.D Dissertation/Master’s Theses
Year
2016
Description
PhD Thesis: Preparation and Biological in vitro and in vivo evaluation of 64Cu-NOTA-Anti ROR1 for diagnosis and follow up of ROR1+ breast carcinoma.
Country/Organization
IRAN
Type
Conference
Year
2016
Description
S. Ait-Mohand, V. Dumulon-Perreault, B. Guérin. A new NPY-Y1R targeting peptide for breast cancer PET imaging. ESRR’16 – 18th European Symposium on Radiopharmacy and Radiopharmaceuticals, April 07-10, 2016, Salzburg, Austria. EJNMMI Radiochem. Chem. 2016, S1 OP05.
Country/Organization
Canada
Type
conference
Year
2018
Description
B. Guérin, New 64Cu peptides for prostate and breast cancers for PET imaging, 2nd Research Coordination Meeting on Copper-64 Radiopharmaceuticals for Theranostic Applications 7-11 May 2018, IAEA Headquarters Vienna, Austria
Country/Organization
Canada
Type
Thesis
Year
2017
Description
R.S.B.H. Schreuder, master thesis entitled:’ Development of 64Cu-labeled radiopharmaceuticals for neuroendocrine tumor detection with positron emission tomography: A comparison between 64Cu-NODAGA-NOC, 68Ga-NODAGA-NOC and 68Ga-DOTA-TOC”
Country/Organization
NETHERLANDS
Type
Journal
Year
2018
Description
Jensen, A.I.; Severin, G.W.; Hansen, A.E.; Fliedner, F.P.; Eliasen, R.; Parhamifar, L.; Kjaer, A.; Andresen, T.L.; Henriksen, J.R. Remote-loading of liposomes with manganese-52 and in vivo evaluation of the stabilities of Mn-52-DOTA and Cu-64-DOTA using radiolabelled liposomes and PET imaging. J. Control. Release 2018, 269, 100–109
Country/Organization
Denmark
Type
Journal
Year
2018
Description
Gutfilen B, Souza SAL, Valentini G. Copper-64: a real theranostic agent. Drug Des Devel Ther Oct 2,12: 3235-3245, 2018.
Country/Organization
Brazil
Type
Conference
Year
2017
Description
C. Zhang, J. Pan, K.-S. Lin, I. Dude, J. Lau, H. Merkens, S. Jenni, B. Guérin, and F. Benard. Improved 68Ga-labelled truncated peptides targeting the neuropeptide Y1 receptor for cancer imaging by positron emission tomography. J Nucl Med 2016 57:1160.
Country/Organization
Canada
Type
IAEA Book Series, PC approved
Year
2020
Description
Copper-64 Radiopharmaceuticals; Production, Quality Control and Clinical Applications
Country/Organization
IAEA
Type
conference
Year
2020
Description
Hailong Zhao, Tianwei Luo, Xuhu Huang, Zequan Li, Mengyi Chen, Lin Xu, Ning Wang, Xuesong Deng, Jin Du, Hongyu Li. Preparation and preliminary biodistribution study of 64Cu-NODAGA-NOC. Abstract. 10th International conference on isotopes, 2020, Feb. 3-7.
Country/Organization
China